Article Sidebar

Submitted
Apr 20, 2021
Published
Apr 20, 2021
Download
PDF
Statistic
Read Counter : 43 Download : 29

Main Article Content

Abstract

Aim of the study-The Study was designed to assess the awareness of Pharmacovigilance and Adverse Drug Reaction (ADR’s) reporting and to evaluate the impact of an educational intervention.


Materials and methods-This was a questionnaire based pre- and post-test educational interventional study. Students were given handouts containing information about pharmacovigilance and ADR’s reporting one week before the educational intervention.  A pre-validated 20-point questionnaire on (KAP) Knowledge, attitude, perceptions about Pharmacovigilance and Adverse Drug Reaction (ADR’s) Reporting was distributed to 5th term medical students (n=47). An interactive educational intervention (Power point presentation) was designed. The chi-square test and unpaired paired t-test was used for statistical calculation.


Results- The overall response rates were expressed as percentages, Mean±SD. The Knowledge, attitude and perceptions of pharmacovigilance and adverse drug reactions when compared before (pre-KAP) and after (post-KAP) the educational intervention, the correct response rates were found to be statistically significant (P<0.001).The feedback from the students was encouraging, handouts before the lecture classes helped them to easily grasp the pharmacovigilance and adverse drug reactions concepts better during lectures.


Conclusion-The study concluded that imparting the knowledge about pharmacovigilance and ADR’s reporting promotes drug safety and rational use of medicines in future.

Keywords

Continuous medical education Pharmacovigilance ADR’s reporting KAP questionnaire

Article Details

How to Cite
Harish. G. Bagewadi, Venkatadri.T.V, & Swapna. R. Nayaka. (2021). Impact of educational intervention on knowledge, attitude, perceptions of pharmacovigilance and adverse drug reactions in fifth term medical students and their feed back. International Journal of Research in Pharmacology & Pharmacotherapeutics, 4(2), 164-174. https://doi.org/10.61096/ijrpp.v4.iss2.2015.164-174
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. Von Laue NC, Schwappach DL, Koeck CM. The epidemiology of preventable adverse drug events: a review of literature. Wien KlinWochenschr, 2003;115(12):407-415.
  2. [2]. Wu WK, Pantaleo N et al. Evaluation of outpatient adverse drug reactions leading to hospitalization. American Journal of Health System Pharmacy,2003;60(3):253-259.
  3. [3]. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta analysis of prospective studies. Journal of the American Medical Association, 1998;279(15):1200-1205.
  4. [4]. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. British Medical Journal, 2004;329(7456):15-19.
  5. [5]. Figueiras A, Tato F, Fontainas J, Gestal-Otero JJ et al: Influence of physicians’ attitudes on reporting adverse drug events: a case control study. Medical Care, 1999;37(8):809-814.
  6. [6]. Williams D, Feely J. Underreporting of adverse drug reactions: attitudes of Irish doctors. Irish Journal of Medical Science,1999;168:257-261.
  7. [7]. Perlik F, Slanar O, Smid M, Petracek J et al: Attitude of Czech physicians to adverse drug reaction reporting, European Journal of Clinical Pharmacology,2002;58:367- 369.
  8. [8]. Belton KJ, Lewis SC, Payne S, Rawlins MD et al: Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom, British Journal of Clinical Pharmacology,1995;39:223- 226.
  9. [9]. Hasford J, Goettler M, Munter KH, Muller- Oerlinghausen B et al: Physicians’ knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions, Journal of Clinical Epidemiology,2002;55:945-950.
  10. [10]. Herdeiro MT, Figueiras A, Polo´ nia J, Gestal- Otero JJ et al: Physicians’ attitudes and adverse drug reaction reporting: a case control study in Portugal, Drug Saf, 2005;28:825-833.
  11. [11]. Hepler CD. Clinical pharmacy, pharmaceutical care, and the quality of drug therapy, Pharmacotherapy,2004;24:1491-8.
  12. [12].V. Lokesh Reddy. Assessment of Knowledge, Attitude and Perception of Pharmacovigilance and Adverse Drug Reaction (ADR’s)Reporting among the Pharmacy Students in South India. IOSR Journal of Pharmacy and Biological Sciences,2014;9( 2):34-43.
  13. [13]. Radhakrishnan R, Vidyasagar S, Varma DM. An Educational Intervention to assess Knowledge Attitude Practice of pharmacovigilance among Health care professionals in an Indian tertiary care teaching hospital. Int.J. PharmTech Res, 2011;3(2):678-92.
  14. [14].Cosentino M, Leoni O, Banfi F, Lecchini S, Frigo G: Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district. Pharmacol Res, 1997;35:85-88.
  15. [15]. Figueiras A, Herdeiro MT, Polonia J, Gestal-Otero JJ: An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA 2006;296:1086-1093.
  16. [16]. Suveges LG, Gesy KF, Wallace SM, Blackburn JL, Appel WC. Adverse drug reaction reporting part II: evaluation of the Saskatchewan pilot project for a regional reporting program in Canada. Drug Information Journal, 1995; 29:581-589.
  17. [17]. Scolt HD et al. Physician reporting of adverse drug reactions: results of the Rhode Island adverse drug reaction reporting project. JAMA 1990;263:1785-1788.
  18. [18]. Chatterjee S, Lyle N, Ghosh S: A survey of the knowledge, attitude and practice of adverse drug reaction reporting by clinicians in eastern India. Drug Saf, 2006;29:641-642.
  19. [19]. Li Q, et al. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chin Med J, 2004;117:856-861.